Savonix Announces Publication in Cognition, Brain, Behavior

SAN FRANCISCO–(BUSINESS WIRE)–Savonix, a global leader in digital tests for cognitive health, announced today that the company has published a research paper in the peer-reviewed medical journal Cognition, Brain, Behavior.

The article, titled: “The impact of lures on a mobile digitized n-back,” outlines a new digitized version of the n-back test, a routinely used instrument in neurocognitive research, as a cognitive tool to evaluate for the effects of lures in a 2-back task. The research study had 1314 participants, ranging from 15 to 76 years of age, who agreed to participate and were part of a larger validation study. The study evaluated whether there was an added cognitive cost that a lure would elicit and assumed it would adversely affect performance.

The results indicated that the occurrence of a lure seemed to have a facilitatory effect in terms of faster response time to targets when a lure was present. Because a 2-back task can be cognitively challenging, the researchers also had expected that over the course of the 60-trial test that subjects would exhibit cognitive fatigue as manifested by slower response time and decreased accuracy.

Instead, the study found that subjects’ performance improved in both response time and accuracy over the course of the test whether lures were present or not. Additionally, the study postulated that the modality and paradigm used in n-back studies may be considered as significant factors when comparing different studies.

“We are excited to have our research study published in the prestigious journal, Cognition, Brain, Behavior, as it validates our Savonix mobile cognitive assessment both as a research and clinical tool. The fact that the study subjects’ performance improved in both response time and accuracy, without cognitive fatigue is interesting and will be useful to compare clinical populations, such as traumatic brain injury (TBI), where cognitive fatigue is a known factor,” said Dr. Mylea Charvat, CEO & Founder at Savonix.

About Savonix

Savonix delivers a fully mobile assessment of cognitive function available on Android and iOS for phone and tablet, the Savonix Cognitive Assessment platform is an accurate, accessible and affordable tool for professional cognitive screens. It empowers healthcare providers, payers and researchers to evaluate and leverage results to improve health and treatment outcomes. Led by clinical neuropsychologists and digital health technology experts, the company has established itself as an authority on cognition globally. To learn more about Savonix, visit Savonix.com.

Contacts

Savonix

Kimberly Ha

KKH Advisors

kimberly.ha@kkhadvisors.com

917-291-5744

Staff

Recent Posts

Cantargia Reports Progress Towards Start of DOD-Sponsored Clinical Trial of Nadunolimab in Leukemia

LUND, SWEDEN / ACCESSWIRE / March 27, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq…

6 mins ago

RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting

Relief Therapeutics Calls Extraordinary General Meeting Anticipated Board of Directors OverhaulGENEVA, SWITZERLAND / ACCESSWIRE /…

6 mins ago

PhotoPharmics Launches Largest Phototherapy Trial for Parkinson’s Disease

Pivotal Trial for Improving Overall Function and Quality of LifeSALT LAKE CITY--(BUSINESS WIRE)--#medicaldevices--PhotoPharmics, a pioneer…

9 hours ago

AARC Celebrates Introduction of the SOAR Act in the House of Representatives

Bill passage key to supplemental oxygen access and adequate reimbursementIRVING, TX / ACCESSWIRE / March…

12 hours ago

She Is Not Skipping a Beat, and Patients Are Noticing

NORTHAMPTON, MA / ACCESSWIRE / March 26, 2024 / Quest Diagnostics At Quest for 2…

12 hours ago